İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2018 · article

Sorafenib reveals anti-arthritic potentials in collagen induced experimental arthritis model.

Dergi Archives of Rheumatology
ISSN1309-0291
YÖKSİS OpenAlex Açık erişim · diamond TR Index
Yıl2018
Atıf15OpenAlex
Yüzdelik%76,6
FWCI1,11,00 = dünya ortalaması
Scopus (SJR)Q4
WoS (JCR)Q4

Veri kaynağı ayrımı

  • YÖKSİSYÖKSİS makale kaydı
  • YÖKSİS dergi adıArchives of Rheumatology
  • OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)
  • Semantic Scholaratıf sayısı (OpenAlex ile birleştirilmez)

Özet

OpenAlex İngilizce

OBJECTIVES: This study aims to examine the effects of sorafenib on a collagen-induced arthritis model. MATERIALS AND METHODS: The study included 50 randomly selected female Wistar-albino rats (8-10-week-old, weighing between 200 g to 250 g). The rats were divided into five equal groups as control, arthritis, etanercept, sorafenib high-dose, and sorafenib low-dose groups, respectively. Arthritis was induced by injecting mixed intradermal chicken type II collagen and incomplete Freund's adjuvant. Twenty-four hours after the advent of arthritis; rats in group 3 were injected subcutaneous etanercept (6 mg/kg/week), while those in groups 4 and 5 were given sorafenib (10 or 30 mg/ kg/day) orally until they were sacrificed on the 34th day. The rat claws and trunk bloods were carefully examined to note perisynovial inflammation and cartilage/bone injury through histopathology. Tissue vascular endothelial growth factor (VEGF) and VEGF receptor levels were carefully checked using western blot analysis. RESULTS: Analysis of the experimental data showed that collagen-induced arthritis decreased in treatments groups after 12-13 days and 34th day in contrast with the arthritis group. Histopathological examination revealed broad perisynovial inflammation and cartilage/bone break down in the arthritis group. Compared to the control group, tissue VEGF and VEGF receptor levels increased in the arthritis group. Sorafenib and etanercept decreased tissue VEGF and VEGF receptor levels, perisynovial inflammation, damage of cartilage/bone. CONCLUSION: Our findings indicate that sorafenib treatment ameliorates collagen-induced arthritis with anti-VEGF effectiveness.

Konular

Atıflar

OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.

15atıfOpenAlex · cited_by_count (önbellek / veritabanı)

Yazarlar

9
  1. NEVZAT GÖZEL 1
  2. MAŞALLAH ÇAKIRER 2
  3. AHMET KARATAŞ 3
  4. MEHMET TUZCU FIRAT ÜNİVERSİTESİ 4
  5. FETHİ AHMET ÖZDEMİR 5
  6. ADİLE FERDA DAĞLI İZMİR BAKIRÇAY ÜNİVERSİTESİ 6
  7. KAZIM ŞAHİN 7
  8. SÜLEYMAN SERDAR KOCA 8
  9. KAZİM ŞAHİN FIRAT ÜNİVERSİTESİ 9